$BUD

Anheuser Busch InBev SA/NV (0RJI) Receives a Buy from RBC Capital

RBC Capital analyst James Edwardes Jones reiterated a Buy rating on Anheuser Busch InBev SA/NV and set a €85.00 price target. The article also notes another Buy from Bernstein, while Barclays downgraded the stock to Hold on July 27. It cites a €74.68 one-year high and €48.87 low.

Original reporting
Published Jul 31, 2026, 2:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 3:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Anheuser Busch InBev SA/NV (0RJI) Receives a Buy from RBC Capital — source image
Decision brief

The 30-second read

$BUDNeutralLow
01

Why it matters

For traders, the actionable element is the change in sell-side positioning (Buy vs Hold) with a specific target, but there is no new operational or financial datapoint to reprice fundamentals.

02

Market read

This is a rating/target update with mixed sell-side signals, likely to have modest impact without new fundamentals.

03

What to watch

The article omits the underlying thesis for the €85 target and the rationale for Barclays’ downgrade, which are typically what drive follow-through.

Relevance 4/10Novelty 3/10Timing: today’s analyst note (RBC Buy with €85 target)

Background

The piece summarizes competing sell-side calls on Anheuser Busch InBev, citing RBC’s Buy and Barclays’ recent downgrade.

Company-level read

Ticker impact

$BUDNeutralMedium confidence
Context

RBC Capital maintained a Buy on Anheuser Busch InBev with a €85.00 price target, while Barclays downgraded it to Hold on July 27.

Expected impact

Likely limited near-term impact unless additional thesis details or earnings catalysts emerge; could support dip-buying versus the Hold.

Evidence & confidence

The article is an analyst-rating update with a stated target, but it does not include new earnings, guidance, regulatory, or operational facts beyond the rating actions.

Market effects

Consumer Defensive sentiment may see minor read-through from competing analyst stances on large brewers.

Primarily affects European large-cap beer sentiment; limited spillover beyond the sector.

Low, as the catalyst is analyst positioning rather than a global macro or regulatory event.

Counterpoint

Barclays’ Hold could reflect valuation or margin risk that the RBC target does not address; the Buy reiteration may be more sentiment than signal.

Key entities

  • Anheuser Busch InBev SA/NV

    Subject of the article, with RBC Buy and Barclays Hold mentioned, plus a €85.00 target and recent downgrade.

  • RBC Capital

    Maintained a Buy rating and set a €85.00 price target in a report released today.

  • Barclays

    Downgraded Anheuser Busch InBev to Hold on July 27.

Related articles

$MSFTHighAI 8/10

Stocks making the biggest moves premarket: Meta, Microsoft, Teladoc, Norwegian Cruise Line & more

Premarket movers include Microsoft shares up about 9% after quarterly revenue of $90.01B beat estimates and Azure grew 43% at constant currency, with 2026 Azure revenue forecast above $100B. Meta fell nearly 9% on EPS and revenue forecast misses. Other notable moves: Teladoc -18.5%, Norwegian Cruise Line -7%, Starbucks +6%, Carvana -10%, MarketAxess halted on a $167/share buyout by ICE.

$BUDMed

AB InBev Reports Second Quarter 2026 Results

AB InBev reported 2Q26 results, saying revenue rose 5.6% and beer volumes grew 1.1%. Underlying EPS increased 23.4%. EBITDA was up 5.8% and free cash flow rose to $3.9 billion, up $2.5 billion vs HY25. Net debt to EBITDA improved to 2.86x. BEES Marketplace GMV rose 50% to $1.2 billion.

$BUDMed

Stay away from this beer giant as Brazil 'sin tax' and post-World Cup hangover weigh on the stock, says Barclays

Barclays downgraded Anheuser-Busch InBev (ABI) to equal weight from overweight, citing Brazil’s planned “sin tax” on health-harming goods and post-2026 World Cup demand comparisons. Analyst Laurence Whyatt said Brazil Beer is about 11% of ABI revenue and 48% of Ambev EBITDA, with the tax starting Jan 2027. Barclays also flagged ABI’s valuation above peers.

$BUDMedAI 8/10

Anheuser-Busch InBev SA/NV (BUD): A Top Sin Stock to Buy Amid Expansion Plans

Anheuser-Busch InBev said May 13 it will invest $5 million to expand its Columbus, Ohio brewery to boost production of Michelob ULTRA and Michelob ULTRA Zero, as part of a $600 million “Brewing Future” initiative. The company reported 1Q revenue up 5.8% and EPS up 20.8% to $0.97, citing costs and FX. Full-year EBITDA is expected to rise within a 4%-8% medium-term range.